Metacrine Inc (MTCR)

$0.58

up-down-arrow $-0.01 (-1.29%)

As on 20-Jun-2023 15:11EDT

Market cap

info icon

$25 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.4

Div. Yield

info icon

0 %

Metacrine Inc (MTCR) Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: -- High: --

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-38 Mln

  • ROEROE information

    -0.9 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    0.7

  • Debt to EquityDebt to Equity information

    0.3

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-1.1

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    43,832,800

6 Years Aggregate

CFO

$-156.23 Mln

EBITDA

$-149.22 Mln

Net Profit

$-150.82 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Metacrine Inc (MTCR)
29.8 2.4 2.0 23.7 -- -- --
BSE Sensex*
-10.9 -4.9 -8.9 -7.6 6.9 8.3 11.5
As on 20-Jun-2023  |  *As on 22-May-2026
Company
2022
2021
Metacrine Inc (MTCR)
-33.5 -91.4
BSE Sensex
4.4 22.0
BSE Sensex
4.4 22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Metacrine Inc (MTCR)
0.6 25.5 0.0 -39.3 -- -94.2 -- 0.4
75.0 10,307.9 622.0 -300.9 -30.1 -62 -- 17.6
76.9 10,379.7 105.8 -829.6 -715.0 -- -- 60.5
50.2 12,233.5 2,375.5 833.4 40.8 40.7 16.1 6.5
119.0 13,020.0 1,080.2 -433.2 -39.8 -- -- 60.9
68.3 8,152.3 1,508.5 348.8 57.0 96.4 24.1 36.2
299.5 8,785.0 417.3 225.0 42.8 18.6 39.9 6.8
517.3 11,800.4 1,132.5 -309.4 -25.5 -52.9 -- 21.7
432.8 11,992.5 2,678.3 460.4 21.1 103.2 26.4 20.0
343.6 8,938.2 0.0 -326.5 -- -37.2 -- 6.3

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Metacrine Inc (MTCR)

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of...  ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.  Read more

  • Pres, CEO & Director

    Dr. Preston S. Klassen M.D., M.H.S.

  • Pres, CEO & Director

    Dr. Preston S. Klassen M.D., M.H.S.

  • Headquarters

    San Diego, CA

  • Website

    https://www.metacrine.com

Edit peer-selector-edit
loading...
loading...

FAQs for Metacrine Inc (MTCR)

The share price of Metacrine Inc (MTCR) is $0.58 (NASDAQ) as of 20-Jun-2023 15:11 EDT. Metacrine Inc (MTCR) has given a return of 23.7% in the last 1 years.

Since, TTM earnings of Metacrine Inc (MTCR) is negative, P/E ratio is not available.
The P/B ratio of Metacrine Inc (MTCR) is 0.40 times as on 20-Jun-2023, a 90 discount to its peers’ median range of 4.08 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2021
-0.30
0.32
2020
-1.97
0.79
2019
--
--
2018
--
--
2017
--
--

The 52-week high and low of Metacrine Inc (MTCR) are Rs -- and Rs -- as of 23-May-2026.

Metacrine Inc (MTCR) has a market capitalisation of $ 25 Mln as on 20-Jun-2023. As per SEBI classification, it is a company.

Before investing in Metacrine Inc (MTCR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.